Close
Close

Lassa Lineage IV Virus-like Particles (LASV IV VLPs) (CAT#: VLP-031YF)

Datasheet
Recombinant Lassa Lineage IV Virus-like Particles (LASV IV VLPs) are produced in mammalian HEK293 cells, assembled with Z, GPC and NP antigens. VLP is mimicking the native 3D structure of viruses which can elicit strong immune responses. However, VLPs lack viral genomic material which makes them non-infectious, unable to replicate and enhance the safety during manufacture and administration. LASV IV VLPs can be used in the development of LASV IV diagnostics and in vaccine development and R&D (including use as an immunogen).

Product Specifications

  • Structural Proteins
  • Z, GPC and NP proteins
  • Expression Systems
  • HEK293 expression system
  • Buffer
  • Tris NaCl containing EDTA, glycerol, arginine and glutamic acid
  • Form
  • Liquid
  • Alternative Names
  • Lassa Lineage IV virus-like particles; LASV IV VLPs; Lassa Lineage IV virus; LASV IV virus-like particles; VLPs; Virus-like Particles
  • Storage
  • Store at 4°C short term (2-4 weeks). Store at -80 °C long term. Avoid repeated freeze/thaw cycles.

Virus Background

  • Virus Family
  • Arenaviridae
  • Virus Species
  • Lassa Virus Lineage IV
  • Virus Overview
  • Lassa virus, an Old World arenavirus (family Arenaviridae), is the etiological agent of Lassa fever, a severe human disease that is reported in more than 100,000 patients annually in the endemic regions of West Africa with mortality rates for hospitalized patients varying between 5-10%. Lassa virus causes Lassa fever, a hemorrhagic disease characterized by fever, generalized weakness, muscle pain, nausea and vomiting with mucosal bleeding. Arenaviruses have pleomorphic virions from 40 to more than 200 nm in diameter that consist of nucleocapsid surrounded by a lipid envelope.
  • Virus Structure
  • Enveloped, single-stranded, and bi-segmented RNA virus
  • Related Disease
  • Lassa hemorrhagic fever

Customer reviews and Q&As    

Customer Review

Better reactivity in ELISA assay

Among the diagnostic methods developed for LASV II, LASV II VLP showed better response in ELISA assay.
2022-12-30

All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.

Related Products
Online Inquiry
CONTACT US
USA:
Europe:
Germany:
Call us at:
USA:
UK:
Germany:
Fax:
Email:
Our customer service representatives are available 24 hours a day, 7 days a week. Contact Us
© 2024 Creative Biolabs. | Contact Us